Correction: Ultra‑rare TP53 and KRAS variants predict survival in ICI‑treated solid tumours.
- DOI
- 10.1007/s12094-026-04379-5
- Published
- 2026 Sep
- Container
- Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s12094-026-04379-5,
title = {Correction: Ultra‑rare TP53 and KRAS variants predict survival in ICI‑treated solid tumours.},
author = {Clemente-Suárez VJ and Olivares R and Yáñez-Sepúlveda R and Guzmán-Muñóz E and Rodríguez AM},
year = {2026},
journal = {Clinical \& translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico},
doi = {10.1007/s12094-026-04379-5},
url = {https://doi.org/10.1007/s12094-026-04379-5}
}RIS
TY - JOUR TI - Correction: Ultra‑rare TP53 and KRAS variants predict survival in ICI‑treated solid tumours. AU - Clemente-Suárez VJ AU - Olivares R AU - Yáñez-Sepúlveda R AU - Guzmán-Muñóz E AU - Rodríguez AM PY - 2026 JO - Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico DO - 10.1007/s12094-026-04379-5 UR - https://doi.org/10.1007/s12094-026-04379-5 ER -
APA
VJ, C., R, O., R, Y., E, G., & AM, R. (2026). Correction: Ultra‑rare TP53 and KRAS variants predict survival in ICI‑treated solid tumours.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. https://doi.org/10.1007/s12094-026-04379-5
Source records
- pubmed · retrieved 2026-09-26T17:12:05.192Z
- europe-pmc · retrieved 2026-09-26T17:12:05.206Z